Work

Inositols in the Treatment of Insulin-Mediated Diseases

Year: 2016
Type: review
Abstract: A growing body of research is currently focused on the role of inositol isomers and in particular myo-inositol (MYO-INS) and D-chiroinositol (DCI) in the treatment of insulin resistance states. Both isomers have been shown to exert insulin-mimetic action and to lower postprandial glucose. Further, insulin resistance-related diseases were associated to derangements in inositol metabolism. Thus, the aim of this review is to provide current evidence on the potential benefits of inositol isomers (MYO-INS and DCI) in the treatment of disease associated to insulin resistance such as polycystic ovary syndrome (PCOS), gestational diabetes, and metabolic syndrome. Finally, molecular insights into inositol insulin-sensitizing effects will be covered focusing on the possible role of inositol glycans as insulin second messengers.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,830
OpenAlex ID: W2517001249
FWCI: 1.022
Cites: 52
Cited by: 63
Related to: 9